AKR7A3 suppresses tumorigenicity and chemoresistance in hepatocellular carcinoma through attenuation of ERK, c-Jun and NF-κB signaling pathways.
about
AKR7A3 suppresses tumorigenicity and chemoresistance in hepatocellular carcinoma through attenuation of ERK, c-Jun and NF-κB signaling pathways.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
AKR7A3 suppresses tumorigenici ...... and NF-κB signaling pathways.
@en
AKR7A3 suppresses tumorigenici ...... and NF-κB signaling pathways.
@nl
type
label
AKR7A3 suppresses tumorigenici ...... and NF-κB signaling pathways.
@en
AKR7A3 suppresses tumorigenici ...... and NF-κB signaling pathways.
@nl
prefLabel
AKR7A3 suppresses tumorigenici ...... and NF-κB signaling pathways.
@en
AKR7A3 suppresses tumorigenici ...... and NF-κB signaling pathways.
@nl
P2093
P2860
P50
P356
P1433
P1476
AKR7A3 suppresses tumorigenici ...... n and NF-κB signaling pathways
@en
P2093
Dora Lai-Wan Kwong
Raymond Kwok Kei Chow
Sarah Tsz-Kwan Sin
Tim Hon Man Chan
Yangyang Song
P2860
P304
83469-83479
P356
10.18632/ONCOTARGET.12726
P407
P577
2016-10-18T00:00:00Z